NASDAQ · Medical - Devices
Sensus Healthcare, Inc. (SRTS) Stock
$2.95
-0.67%
NASDAQ: SRTS
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Top Premarket Decliners
MT Newswires · Jun 12, 2026
How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes
Simply Wall St. · May 20, 2026
Sensus Healthcare Q1 Earnings Call Highlights
MarketBeat · May 9, 2026
Sensus (SRTS) Q1 2026 Earnings Transcript
Motley Fool · May 7, 2026
Pleasing Signs As A Number Of Insiders Buy Sensus Healthcare Stock
Simply Wall St. · May 6, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held17.63%
Institutions Held28.95%
Institutions Float Held35.14%
Peer Comparison
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is led by CEO Joseph C. Sardano, employs 54 people, headquartered in US, publicly traded since 2016.
Sensus Healthcare, Inc. (SRTS) stock trades at $2.95 with a market capitalization of $48.56M. The stock is valued at a price-to-earnings (P/E) ratio of -3.18, price-to-book of 1.33, price-to-sales of 2.80. Over the past 52 weeks the stock has ranged between $2.66 and $5.49, and currently trades 46.3% below its 52-week high.
On profitability, Sensus Healthcare, Inc. generates a return on equity (ROE) of -34.09%, return on capital employed of -35.89%, an operating margin of -37.04%, a net profit margin of -88.45%.